Navigation Links
Telik Announces Presentation and Webcast at 14th Annual BIO CEO & Investor Conference
Date:2/8/2012

PALO ALTO, Calif., Feb. 8, 2012 /PRNewswire/ -- Telik, Inc. (Nasdaq: TELK) today announced that CEO Michael M. Wick, M.D., Ph.D. will provide a corporate overview at the 14th Annual BIO CEO & Investor Conference in New York City on Tuesday, February 14 at 1:00 p.m. Eastern time (10:00 a.m. Pacific time), in the Waldorf-Astoria Hotel's Conrad Suite.  A live and archived webcast of the presentation will be available on the Telik website, www.telik.com.  The archived broadcast of the presentation can be accessed for 30 days following the presentation.

About Telik

Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer.  The company's most advanced drug candidate is Telintra®, a modified glutathione analog intended for the treatment of hematologic malignancies including myelodysplastic syndrome; followed by Telcyta®, a cancer activated prodrug for the treatment of a variety of cancers. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP®, which enables the rapid and efficient discovery of small molecule drug candidates.

Telik, the Telik logo, TELINTRA, TELCYTA and TRAP are trademarks or registered trademarks of Telik, Inc.


'/>"/>
SOURCE Telik, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
2. Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2
3. Telik Announces Telintra Presentation at American Society of Hematology Annual Meeting
4. Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
5. Teliks Proteasome Inhibitor Program Meets a Preclinical Development Milestone
6. Telik Announces Presentation at ASCO Annual Meeting
7. Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
8. Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
9. Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revlimid(R)) in Patients With Myelodysplastic Syndrome (MDS)
10. Telik Announces Third Quarter 2009 Financial Results
11. Telik Announces Fourth Quarter and 2009 Year End Financial Results and 2010 Financial Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... July 28, 2015 Research and Markets ... the "Global Hearing Aids Market 2015-2019" ... global hearing aids market to grow at a ... Factors such as changing demographics and ... growth. The market has witnessed immense technological advances. ...
(Date:7/28/2015)... July 28, 2015  Leaf Healthcare releases white ... ulcers place on the healthcare system . ... to modern quality healthcare. Research by the U.S. ... Healthcare Research and Quality shows that pressure ulcers ... billion a year. The condition is both excruciatingly ...
(Date:7/28/2015)... July 28, 2015   CSL Behring ... a Marketing Authorization Application (MAA) for the company,s ... IX with recombinant albumin (rIX-FP) for the prophylaxis ... Hemophilia B. Upon Swissmedic approval, rIX-FP will provide ... with dosing intervals up to 14 days. ...
Breaking Medicine Technology:Global Hearing Aids Market 2015-2019 with G N Store Nord, Sonova Holdings & William Demant Dominating 2Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 2Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 3Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 2Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 3Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 4
(Date:7/28/2015)... ... July 28, 2015 , ... ... biologics and biologic-device combination products for the treatment of bone disorders and conditions ... Patent No. 9,062,300 entitled "Fusion Proteins of Collagen Binding-Domain and Parathyroid Hormone". The ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... to include a proprietary, web based clinical knowledge system, called “Referral Guidance.” ... based. It provides physicians who are anticipating making a subspecialty referral an ...
(Date:7/28/2015)... ... July 28, 2015 , ... Every summer, the public is reminded ... caution when lighting fireworks in their own neighborhoods. Unfortunately, according to a recent report ... 3, 2015 USA Today article " Eye Injuries Caused by Fireworks Doubled in Last ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... (ACS-Heart Attack, Sudden Death, or Angina), many of whom are missed by conventional ... of individuals with active yet undetected sub-clinical disease, who are at risk of ...
(Date:7/28/2015)... ... July 28, 2015 , ... There has been much discussion in ... bridges and railroads, often overlooked is the over 740,000 miles of municipal sewer ... into sewage treatment facilities. According to the American Society of Civil Engineers , ...
Breaking Medicine News(10 mins):Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:Introducing Care to Care’s New Web Based “Referral Guidance” Program 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 3Health News:Utility of a novel coronary artery disease biomarker algorithm in modifying physician adherence to guideline therapy presented at 20th World Congress on Heart Disease 2Health News:With an Infrastructure Spending Bill on the Horizon, RestorationEze Discusses the Impact an Aging Sewer System is Having on Homeowners 2Health News:With an Infrastructure Spending Bill on the Horizon, RestorationEze Discusses the Impact an Aging Sewer System is Having on Homeowners 3
... will include lots of green vegetables, less of saturated fats// and ... the first of its kind in fifteen years. ... One cannot be very sure about Canadians following this advice seriously. ... the type of diet prescribed by the Food Guide may affect ...
... study conducted by the scientists at Western Infirmary Epilepsy ... as a single therapy. This study was published in ... study which had around six hundred participants who had ... last year to the drug levetiracetam or to controlled ...
... Advertising campaign pointing out the threat of losing vision ... in young population//. This was cited by the British ... National Institute of the Blind, losing vision is considered ... like stroke and lung cancer associated with it. Hence ...
... Clinical Pediatrics, it is reported that breast feeding mothers may ... care of, their children// may not be affected by vitamin ... team belonging to University of Michigan conducted a study among ... Twenty of the mothers were found to be deficient in ...
... Network (SIGN) has published a set of guidelines that ... complaints// like heart attacks and strokes in the next ... preventive treatment to about 500,000 people considered to be ... assessments for all over-40s especially those most at risk ...
... Thimphu: Sonam Choden, the mother of two-year-old Leki Dorji, never ... Christian Medical College in India's Tamil// Nadu state, which treated ... and also talk". ,Choden, an uneducated 23-year-old ... in her child was the happiest moment in her life, ...
Cached Medicine News:Health News:A New Plan to Restrict Cardiovascular Diseases in Scotland 2
Very concise book answering the question: "I've got a diagnosis, which drugs do I use?". All 15 chapters written by highly skilled US specialists...
... Guide for Nurses with Integrated Calculators, based ... is a remarkable advance in drug reference. ... Davis s Drug Guide (9th Edition) and ... based medications. This product merges many of ...
Allows health professionals to answer consumers' questions regarding safety issues concerning possible drug-herb and drug-food interactions....
... DrDrugs®: Drug Guide ... with over 760 Integrated ... most comprehensive, up-to-date and ... built in drug dosing ...
Medicine Products: